Carbohydrate modified diet & insulin sensitizers reduce body weight & modulate metabolic syndrome measures in EMPOWIR (enhance the metabolic profile of women with insulin resistance): A randomized trial of normoglycemic women with midlife weight gain

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Mogul, Harriette R ^a   Freeman, Ruth ^b   Nguyen, Khoa ^a   Frey, Michael ^a   Klein, Lee Ann ^a   Jozak, Sheila ^b   Tanenbaum, Karen ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LEPTIN; METFORMIN; PLACEBO; ROSIGLITAZONE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLACK PERSON; BODY MASS; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE TOLERANCE; HISPANIC; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LOW CALORY DIET; LOW CARBOHYDRATE DIET; LOW DRUG DOSE; LOW FAT DIET; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT CONTROL; WEIGHT GAIN; WEIGHT REDUCTION; ADVERSE EFFECTS; BODY WEIGHT; CLINICAL TRIAL; FOLLOW UP; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; RISK FACTOR; TREATMENT OUTCOME;

BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DIET, CARBOHYDRATE-RESTRICTED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LEPTIN; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT COMPLIANCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84907908984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108264     Document Type: Article

References (58)

1. Kuczmarski RJ (1992) Prevalence of overweight and weight gain in the United States. Am J Clin Nutr 55: 495S-502S.
2. Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, et al. (1990) Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132: 501-513.
3. Colditz GA, Willett WC, Rotnitzky A, Manson JE (1995) Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122: 481-486.
4. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, et al. (1995) Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 273: 461-465.
5. Kannel WB, D'Agostino RB, Cobb JL (1996) Effect of weight on cardiovascular disease. Am J Clin Nutr 63: 419S-422S.
6. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, et al. (1995) Body weight and mortality among women. N Engl J Med 333: 677-685.
7. Seidell JC, Oosterlee A, Deurenberg P, Hautvast JG, Ruijs JH (1988) Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age. Eur J Clin Nutr 42: 805-815.
8. Mogul HR, Marshall M, Frey M, Burke HB, Wynn PS, et al. (1996) Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women. J Clin Endocrinol Metab 81: 4492-4495.
9. Mogul HR, Weinstein BI, Mogul DB, Peterson SJ, Zhang S, et al. (2002) Syndrome W: a new model of hyperinsulinemia, hypertension and midlife weight gain in healthy women with normal glucose tolerance. Heart Dis 4: 78-85.
10. Dunaif A, Segal KR, Futterweit W, Dobrjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38: 1165-1174.
11. Saenger P, DiMartino-Nardi J (2001) Premature adrenarche. J Endocrinol Invest 24: 724-733.
12. Ibanez L, Potau N, Francois I, de ZF (1998) Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83: 3558-3562.
13. Mogul HR, Peterson SJ, Weinstein BI, Zhang S, Southren AL (2001) Metformin and carbohydrate-modified diet: a novel obesity treatment protocol: preliminary findings from a case series of nondiabetic women with midlife weight gain and hyperinsulinemia. Heart Dis 3: 285-292.
14. Mogul HR, Peterson SJ, Weinstein BI, Li J, Southren AL (2003) Long-term (2-4 year) weight reduction with metformin plus carbohydrate-modified diet in euglycemic, hyperinsulinemic, midlife women (Syndrome W). Heart Dis 5: 384-392.
15. Odeleye OE, de Court, Pettitt DJ, Ravussin E (1997) Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 46: 1341-1345.
16. Lustig RH (2008) Which comes first? The obesity or the insulin? The behavior or the biochemistry? J Pediatr 152: 601-602.
17. Corkey BE (2012) Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 61: 4-13.
18. Buettner C (2012) Is hyperinsulinemia required to develop overeating-induced obesity? Cell Metab 16: 691-692.
19. Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE (1998) Beneficial effect of diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab 83: 1911-1915.
20. Lustig RH, Sen S, Soberman JE, Velasquez-Mieyer PA (2004) Obesity, leptin resistance, and the effects of insulin reduction. Int J Obes Relat Metab Disord 28: 1344-1348.
21. Alemzadeh R, Slonim AE, Zdanowicz MM, Maturo J (1993) Modification of insulin resistance by diazoxide in obese Zucker rats. Endocrinology 133: 705-712.
22. Alemzadeh R, Jacobs W, Pitukcheewanont P (1996) Antiobesity effect of diazoxide in obese Zucker rats. Metabolism 45: 334-341.
23. Mehran AE, Templeman NM, Brigidi GS, Lim GE, Chu KY, et al. (2012) Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab 16: 723-737.
24. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK (1986) Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med 315: 220-224.
25. Mogul HR, Marshall M, Frey M, Burke HB, Wynn PS, et al. (1996) Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women. J Clin Endocrinol Metab 81: 4492-4495.
26. Mogul HR, Weinstein BI, Mogul DB, Peterson SJ, Zhang S, et al. (2002) Syndrome W: a new model of hyperinsulinemia, hypertension and midlife weight gain in healthy women with normal glucose tolerance. Heart Dis 4: 78-85.
27. Brownell KD, Wadden TA, and LEARN Education Center (1990) The LEARN program for weight control: lifestyle, exercise, attitudes, relationships, nutrition. American Health Pub. Co.
28. 2001. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
30. Levri KM, Slaymaker E, Last A, Yeh J, Ference J, et al. (2005) Metformin as treatment for overweight and obese adults: a systematic review. Ann Fam Med 3: 457-461.
31. Salpeter SR, Buckley NS, Kahn JA, Salpeter EE (2008) Meta-analysis: metformin treatment in persons at risk for diabetes mellitus. Am J Med 121: 149-157.
32. (2012) Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care 35: 731-737.
33. Wilson DM, Abrams SH, Aye T, Lee PD, Lenders C, et al. (2010) Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. Arch Pediatr Adolesc Med 164: 116-123.
34. Kendall D, Vail A, Amin R, Barrett T, Dimitri P, et al. (2012) Metformin in Obese Children and Adolescents: The MOCA Trial. J Clin Endocrinol Metab.
35. Helvaci MR, Kaya H, Borazan A, Ozer C, Seyhanli M, et al. (2008) Metformin and parameters of physical health. Intern Med 47: 697-703.
36. Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, et al. (1999) High glycemic index foods, overeating, and obesity. Pediatrics 103: E26.
37. Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS (2003) A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med 157: 773-779.
38. Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS (2007) Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA 297: 2092-2102.
39. Foster-Schubert KE, Overduin J, Prudom CE, Liu J, Callahan HS, et al. (2008) Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J Clin Endocrinol Metab 93: 1971-1979.
40. Estruch R, Ros E, Salas-Salvado J, Covas MI, Pharm D, et al. (2013) Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 368: 1279-1290.
41. Zemel MB, Thompson W, Milstead A, Morris K, Campbell P (2004) Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 12: 582-590.
42. Liebman M (2013) When and why carbohydrate restriction can be a viable option. Nutrition. Available: http://dx.doi.org/10.1016/j.nut.2013.11.021.
43. Skov AR, Toubro S, Ronn B, Holm L, Astrup A (1999) Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord 23: 528-536.
44. Krebs NF, Gao D, Gralla J, Collins JS, Johnson SL (2010) Efficacy and safety of a high protein, low carbohydrate diet for weight loss in severely obese adolescents. J Pediatr 157: 252-258.
45. Soenen S, Bonomi AG, Lemmens SG, Scholte J, Thijssen MA, et al. (2012) Relatively high-protein or 'low-carb' energy-restricted diets for body weight loss and body weight maintenance? Physiol Behav 107: 374-380.
46. Kitabchi AE, McDaniel KA, Wan JY, Tylavsky FA, Jacovino CA, et al. (2013) Effects of high-protein versus high-carbohydrate diets on markers of beta-cell function, oxidative stress, lipid peroxidation, proinflammatory cytokines, and adipokines in obese, premenopausal women without diabetes: a randomized controlled trial. Diabetes Care 36: 1919-1925.
47. Bray GA, Smith SR, De JL, Xie H, Rood J, et al. (2012) Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating: a randomized controlled trial. JAMA 307: 47-55.
48. Westerterp-Plantenga MS, Nieuwenhuizen A, Tome D, Soenen S, Westerterp KR (2009) Dietary protein, weight loss, and weight maintenance. Annu Rev Nutr 29: 21-41.
49. Li Z, Heber D (2012) Overeating and overweight: extra calories increase fat mass while protein increases lean mass. JAMA 307: 86-87.
50. Sofer S, Eliraz A, Kaplan S, Voet H, Fink G, et al. (2011) Greater weight loss and hormonal changes after 6 months diet with carbohydrates eaten mostly at dinner. Obesity (Silver Spring) 19: 2006-2014.
51. Mogul HR, Freeman R, Hantash FX (2012) Long-term hormonal adaptations to weight loss. N Engl J Med 366: 381-382.
52. Leibel RL (2008) Molecular physiology of weight regulation in mice and humans. Int J Obes (Lond) 32 Suppl 7: S98-108.
53. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, et al. (2011) Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 365: 1597-1604.
54. Aubert G, Mansuy V, Voirol MJ, Pellerin L, Pralong FP (2011) The anorexigenic effects of metformin involve increases in hypothalamic leptin receptor expression. Metabolism 60: 327-334.
55. Zinman B, Harris SB, Neuman J, Gerstein HC, Retnakaran RR, et al. (2010) Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Lancet 376: 103-111.
56. Li X, Zhang N, Li Y, Shi Y, Li D, et al. (2011) Effects of metformin and rosiglitazone on peripheral insulin resistance and beta-cell function in obesity: a double-blind, randomized, controlled study. J Int Med Res 39: 358-365.
57. Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457-2471.
58. Ogden CL, Carroll MD, Kit BK, Flegal KM (2013) Prevalence of obesity among adults: United States, 2011-2012. NCHS Data Brief 1-8.